Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
古本朗嗣 - 2008 - nagasaki-u.repo.nii.ac.jp
慢性呼吸器疾患, 特に慢性閉塞性肺疾患 (COPD) における急性増悪は死亡率,
医療費の増加に関与している. 急性増悪は肺炎球菌やインフルエンザによる感染に伴うことが多く …
医療費の増加に関与している. 急性増悪は肺炎球菌やインフルエンザによる感染に伴うことが多く …
Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
A Furumoto, Y Ohkusa, M Chen, K Kawakami… - Vaccine, 2008 - Elsevier
To determine the clinical efficacy of combined vaccination with 23-valent pneumococcal
vaccine (PV) and influenza vaccine (IV) against pneumonia and acute exacerbation of …
vaccine (PV) and influenza vaccine (IV) against pneumonia and acute exacerbation of …
[PDF][PDF] Additive effect of 23-valent pneumococcal polysaccharide vaccine and influenza vaccine on acute exacerbation in older patients with chronic lung disease
J DU, X LIU, T ZHAO, L GU… - Chinese Journal of …, 2012 - manu41.magtech.com.cn
AIM: To assess the effectiveness of 23-valent penumococcal polysaccharide vaccine (PV)
and influenza vaccine (IV) for preventing acute exacerbation in older patients with chronic …
and influenza vaccine (IV) for preventing acute exacerbation in older patients with chronic …
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations
Y Li, P Zhang, Z An, C Yue, Y Wang, Y Liu… - …, 2022 - Wiley Online Library
Background and objective Single‐study evidence of separate and combined effectiveness of
influenza and pneumococcal vaccination in patients with chronic obstructive pulmonary …
influenza and pneumococcal vaccination in patients with chronic obstructive pulmonary …
Pneumococcal vaccination and chronic respiratory diseases
Patients with COPD and other chronic respiratory diseases are especially vulnerable to viral
and bacterial pulmonary infections, which are major causes of exacerbations …
and bacterial pulmonary infections, which are major causes of exacerbations …
[PDF][PDF] 慢性呼吸器疾患患者における肺炎球菌ワクチンの短期効果
綿貫祐司， 高橋宏， 小倉高志， 宮沢直幹， 中村万里… - 日呼吸会誌, 2006 - is.jrs.or.jp
外来通院中の 60 歳以上の慢性呼吸器疾患患者 1,378 人に肺炎球菌ワクチン接種を勧め,
希望者に 2002 年 8 月から 11 月に同ワクチン接種を行った. 接種群 647 人と非接種群 731 …
希望者に 2002 年 8 月から 11 月に同ワクチン接種を行った. 接種群 647 人と非接種群 731 …
Influenza and pneumococcal vaccination in chronic obstructive pulmonary disease (COPD)
MC Arinez-Fernandez, P Carrasco-Garrido… - … Medicine: Copd Update, 2007 - Elsevier
Patients who suffer from chronic obstructive pulmonary disease (COPD) often experience
acute exacerbations, which frequently require hospitalization and lead to increased …
acute exacerbations, which frequently require hospitalization and lead to increased …
Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory …
M Sumitani, Y Tochino, T Kamimori, H Fujiwara… - Internal …, 2008 - jstage.jst.go.jp
Internal Medicine Vol.47 Page 1 1189 □ ORIGINAL ARTICLE □ Additive Inoculation of
Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Lower …
Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Lower …
[HTML][HTML] Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute …
M Fekete, J Pako, AN Nemeth, S Tarantini… - Journal of Thoracic …, 2020 - ncbi.nlm.nih.gov
Background Based on current evidence, vaccination is recommended against the influenza
virus and pneumococcus to avoid serious acute exacerbations in patients with chronic …
virus and pneumococcus to avoid serious acute exacerbations in patients with chronic …
[PDF][PDF] Clinical features and risk factors for mortality in hospitalized older adults with pneumonia
福田信彦， フクダノブヒコ - 2022 - ycu.repo.nii.ac.jp
1. 序論超高齢化社会である日本において, 肺炎は罹患率, 死亡率がともに高い疾患のひとつである.
厚生労働省による 2018 年の人口動態統計では, 肺炎の死亡率は悪性新生物, 心疾患, 老衰 …
厚生労働省による 2018 年の人口動態統計では, 肺炎の死亡率は悪性新生物, 心疾患, 老衰 …